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The transcription factors LAP1, LAP2 and LIP are derived from the Cebpb-mRNA through the
use of alternative start codons. High LIP expression has been associated with human cancer
and increased cancer incidence in mice. However, how LIP contributes to cellular transfor-
mation is poorly understood. Here we present that LIP induces aerobic glycolysis and
mitochondrial respiration reminiscent of cancer metabolism. We show that LIP-induced
metabolic programming is dependent on the RNA-binding protein LIN28B, a translational
regulator of glycolytic and mitochondrial enzymes with known oncogenic function. LIP acti-
vates LIN28B through repression of the let-7 microRNA family that targets the Lin28b-mRNA.
Transgenic mice overexpressing LIP have reduced levels of let-7 and increased LIN28B
expression, which is associated with metabolic reprogramming as shown in primary bone
marrow cells, and with hyperplasia in the skin. This study establishes LIP as an inducer of
cancer-type metabolic reprogramming and as a regulator of the let-7/LIN28B regulatory
circuit.
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Proliferating (cancer) cells generate a diversity of carbonintermediates and reducing power in the form of NADPH,needed for biosynthetic reactions, by markedly increasing
glucose uptake and glucose catabolism. During this process excess
of the cytosolic end product of glycolysis, pyruvate, is converted
into lactate and secreted into the extracellular environment (the
so-called Warburg effect)1,2. In addition, cancer cells increase
mitochondrial activity and boost both the replenishment (ana-
plerosis) and the clearance (cataplerosis) of intermediates of the
TCA cycle. Thereby, the mitochondria serve as a metabolic hub
that produces biomolecule intermediates in addition to energy3.
The metabolic reprogramming of cancer cells is induced by
deregulation or mutations in metabolic enzymes, components of
signalling pathways and gene regulatory factors. LIN28A and its
paralogue LIN28B are such key metabolic reprogramming factors.
As RNA-binding proteins, LIN28A/B stimulate the translation of
several glycolytic and mitochondrial enzymes in the context of
cell metabolism, tissue repair and cancer4–7. Lin28a/b are highly
expressed during embryogenesis but silent in differentiated cells
of adult tissues8. Lin28b is aberrantly high expressed in various
tumour types9,10 and transgenic overexpression is sufficient to
drive cancer and is required for tumour maintenance4,11–13.
LIN28A/B repress the maturation of the let-7 family of micro-
RNAs consisting of nine (a, b, c, d, e, f, g, i and miR-98) func-
tionally redundant microRNAs that originate from eight
conserved let-7 microRNA expressing clusters in humans and
mice14–18. The let-7 microRNAs function as tumour suppressors
by inhibiting the mRNAs of various oncogenes and cell cycle
regulators, including Lin28a/b19,20. Thus, let-7 and Lin28a/b have
reciprocal functions in a regulatory circuit in which let-7 represses
Lin28a/b-mRNAs, while LIN28A/B represses let-7 maturation20.
When addressing the functions of the transcription factor
CCAAT/Enhancer Binding Protein beta (C/EBPβ), it should
always be considered that translation of the Cebpb-mRNA gives
rise to three protein isoforms with different functions21–24. The
isoforms called LAP1 and LAP2 (Liver-enriched transcriptional
activating protein) are complete transcriptional activators,
while the N-terminally truncated isoform LIP (Liver-enriched
inhibitory protein) lacks transactivation domains and acts by
inhibiting the functions of LAP and other C/EBPs through
competitive binding to the same DNA-recognition sites.
Expression of LIP is regulated by a dedicated translation control
mechanism that requires a cis-regulatory upstream open read-
ing frame (uORF) in the Cebpb-mRNA leader sequence (Sup-
plementary Fig. 1a)22–24.
High expression of LIP is associated with breast cancer, ovarian
cancer and anaplastic large cell lymphoma25–32, and cellular
transformation in cell culture22. Furthermore, knockin mice that
either express mono- or bi-allelic LIP-only display enhanced
tumourigenesis33. Together, the studies demonstrate that LIP has
oncogenic capacities, but whether and how metabolic functions of
LIP are involved is not known.
Here we show that LIP enhances aerobic glycolysis and
mitochondrial respiration, resembling cancer cell metabolism.
Using genome wide transcriptome and whole cell proteome
analysis we identify LIN28B as a required mediator of LIP-
controlled metabolic regulation. We provide evidence that LIP
controls Lin28b expression though transcriptional repression of
let-7. Furthermore, analysis of a mouse model with LIP over-
expression confirms the LIP-let-7-Lin28b regulation in vivo,
which is associated with metabolic reprogramming in primary
bone marrow cells and an increase in immature cells as well as
hyperplasia in the skin. Our data suggest an important role of
LIP in controlling the let-7/LIN28B regulatory circuitry and
thereby regulating cellular metabolism and possibly inducing a
tumour prone state.
Results
LIP enhances aerobic glycolysis and mitochondrial metabo-
lism. In the context of earlier studies, we repeatedly observed that
cellular overexpression of LIP but not of LAP results in rapid
acidification of the cell culture medium. Therefore, we investi-
gated a possible involvement of LIP and LAP in the regulation of
cellular metabolism. To examine LIP-dependent cellular meta-
bolism we measured the extracellular acidification rate (ECAR) as
an indicator for glycolytic flux and the oxygen consumption rate
(OCR) as a measure for mitochondrial respiration using the
Seahorse XF96 analyser in wild-type (wt) mouse embryonic
fibroblasts (MEFs) versus MEFs derived from C/EBPβΔuORF mice
that express lower LIP/LAP ratios compared to wt due to defi-
cient endogenous LIP production23,24,34 (Fig. 1a and Supple-
mentary Fig. 1a). Basal ECAR, maximal ECAR (treatment with
ATP synthase inhibitor oligomycin) and basal OCR, but not
maximal OCR (treatment with mitochondrial uncoupler 2,4-
dinitrophenol, DNP), were decreased in C/EBPβΔuORF MEFs
compared to wt MEFs (Fig. 1b). Conversely, ectopic over-
expression of LIP in wt MEFs shifting C/EBPβ expression to
higher LIP/LAP ratios (Fig. 1c) resulted in an increase in basal
and maximal ECAR as well as an increase in maximal OCR
(Fig. 1d). To investigate the function of individual C/EBPβ iso-
forms we separately overexpressed LAP or LIP in immortalized
Cebpb-knockout (ko) MEFs (Fig. 1e). LIP expression was suffi-
cient to induce both higher basal and maximal ECAR and OCR,
while LAP expression resulted only in higher OCRs, albeit not as
strong as LIP (Fig. 1f). Furthermore, expression of LIP in Cebpb-
ko MEFs increased both the ratio of mitochondrial to genomic
DNA (Fig. 1g) and mitochondrial mass as detected by staining
with MitoTracker (Fig. 1h and Supplementary Fig. 1b), while
expression of LAP did not result in noticeable changes. Over-
expression of LIP also increased basal and maximal ECAR and
OCR in the human hepatocellular carcinoma cell line Hepa1-6
and in the breast cancer cell lines BT20 and T47D (Supplemen-
tary Fig. 1c–h). Thus, LIP alone or a high LIP/LAP ratio enhances
the cellular metabolic rate with an increase in both aerobic gly-
colysis and mitochondrial respiration capacity, which is remi-
niscent of cancer cell metabolism.
Proliferating cells, including cancer cells, adjust metabolism
to maintain high ratios of ATP/ADP and NADH/NAD+ that
are required for cell growth, proliferation and survival2. LIP-
deficient C/EBPβΔuORF MEFs maintained lower ATP/ADP
ratios compared to wt cells, while ectopic expression of LIP in
either wt or C/EBPβ-deficient MEFs resulted in an increase in
the ATP/ADP ratio (Fig. 2a). Similarly, the LIP-deficient C/
EBPβΔuORF MEFs maintained lower NADH/NAD+ ratios,
while ectopic expression of LIP in wt MEFs increased the
NADH/NAD+ ratio. In C/EBPβ-deficient MEFs LIP had no
effect on the NADH/NAD+ ratio while LAP reduced the
NADH/NAD+ ratio, indicating that LIP indirectly regulates the
NADH/NAD+ ratio in wt and C/EBPβΔuORF MEFs by
inhibiting the function of LAP (Fig. 2b). Furthermore, the cell
proliferation rate was reduced for the LIP-deficient C/
EBPβΔuORF MEFs compared to wt MEFs, while ectopic
expression of LIP in wt MEFs stimulated proliferation (Fig. 2c).
Finally, ectopic expression of LIP in Cebpb-ko MEFs more
strongly stimulated proliferation than ectopic expression of
LAP (Fig. 2c). To address whether LIP-induced cell prolifera-
tion critically depends on glycolysis or mitochondrial respira-
tion we performed dose-response experiments using either the
glycolytic inhibitor 2-deoxyglucose (2-DG) or the mitochon-
drial complex 1 inhibitor rotenone. Cells expressing LIP were
more sensitive to 2-DG compared to LAP expressing cells or
control cells that have similar dose response curves (Fig. 2d). In
addition, LIP expressing cells were more sensitive to rotenone
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Fig. 1 C/EBPβ-LAP and -LIP isoforms regulate cellular metabolism. a Immunoblot analysis of C/EBPβ-LAP and C/EBPβ-LIP expression in mouse embryonic
fibroblasts (MEFs) derived from wt or C/EBPβΔuORF mice. α-tubulin is used for loading control. Uncropped images are shown in Supplementary Fig. 7.
b Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) of MEFs derived from wt or C/EBPβΔuORF mice (n= 6). c Immunoblot
analysis of C/EBPβ-LAP and C/EBPβ-LIP expression in wt MEFs and with ectopic expression of LIP. α-tubulin is used for loading control. Uncropped images
are shown in Supplementary Fig. 7. d ECAR and OCR of wt MEFs with control empty vector (EV) or ectopic expression of LIP (n= 6). e Immunoblot
analysis of C/EBPβ-LAP and C/EBPβ-LIP expression in Cebpb-knockout (ko) MEFs with control empty vector (EV) or ectopic expression of LIP or LAP. β-
actin is used for loading control. Uncropped images are shown in Supplementary Fig. 7. f ECAR and OCR of Cebpb-ko MEFs with control empty vector (EV)
or ectopic expression of LIP or LAP (n= 6). g Mitochondrial/nuclear DNA ratio and h MitoTracker quantification of Cebpb-ko MEFs with control empty
vector (EV) or ectopic expression of LIP or LAP (n= 7 for EV, n= 6 for LIP and n= 5 for LAP). Statistical differences were analysed by Student’s t-tests.
Error bars represent SD, *P < 0.05, **P < 0.01, ***P < 0. 001
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compared to control cells while LAP expressing cells showed a
strongly reduced sensitivity to rotenone (Fig. 2e).
Taken together, these data suggest that LIP induces a
proliferation-supporting metabolic shift toward enhanced aerobic
glycolysis and mitochondrial respiration and that LIP-expressing
cells depend on these metabolic alterations for enhanced
proliferation.
Regulation by LIP involves post-transcriptional mechanism.
LIP is considered to mainly function by inhibiting transcriptional
activities of LAP and probably of other C/EBP members through
competitive binding to the same DNA-recognition sites.
Although the enhanced metabolism induced by LIP might be
explained by transcriptional upregulation of involved metabolic
genes, the question was if and how LIP as a designated
transcriptional repressor could be involved in such a transcrip-
tional upregulation. To solve this question we studied changes in
transcriptome and proteome induced by LAP or LIP using
Cebpb-ko MEFs that express either LAP or LIP compared to C/
EBPβ-deficient empty vector control cells. Surprisingly, LAP
overexpression only changed the expression of 11 transcripts
compared to the C/EBPβ-deficient empty vector control (Sup-
plementary Fig. 2a). The overexpression of LIP resulted in the
down-regulation of 189 genes and up-regulation of 27 genes;
confirming that LIP mainly functions as a transcriptional inhi-
bitor (Fig. 3a). Function clustering analysis of the downregulated
genes using DAVID (https://david-d.ncifcrf.gov/) revealed that
the three highest enriched clusters consist of genes associated
with extracellular matrix, cell adhesion and collagen subtypes
(Fig. 3b). These genes are involved in cell-cell interactions and
their downregulation might result in an increased migration and
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Fig. 2 C/EBPβ-LAP and -LIP isoforms regulate cellular proliferation. a Relative ATP/ADP ratio in MEFs derived from, wt or C/EBPβΔuORF mice (n= 8), wt
MEFs with control empty vector (EV) or ectopic expression of LIP (n= 4), and Cebpb-ko MEFs with control empty vector (EV) or ectopic expression of LIP
or LAP (n= 6). b Relative NADH/NAD+ ratio in, wt or C/EBPβΔuORF MEFs (n= 6), wt MEFs with control empty vector (EV) or ectopic expression of LIP
(n= 6), and Cebpb-ko MEFs with control empty vector (EV) or ectopic expression of LIP or LAP (n= 6). c Cell population doublings after three days of cell
culture of, wt or C/EBPβΔuORF MEFs (n= 6), wt MEFs with control empty vector (EV) or ectopic expression of LIP (n= 3), and Cebpb-ko MEFs with control
empty vector (EV) or ectopic expression of LIP or LAP (n= 3). d Dose-response curve of inhibition of glycolysis by 2-DG in Cebpb-ko MEFs with control
empty vector (EV) or ectopic expression of LIP or LAP (n= 6). e Dose-response curve of inhibition of mitochondrial respiration by rotenone in Cebpb-ko
MEFs with control empty vector (EV) or ectopic expression of LIP or LAP (n= 6). Statistical differences were analysed by Student’s t-tests. Error bars
represent SD, *P < 0.05, **P < 0.01, ***P < 0. 001
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Fig. 3 LIP differentially regulates transcriptome and proteome. a Differentially expressed genes (DEG) by ectopic expression of LIP in Cebpb-ko MEFs compared
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invasion capacity of high LIP expressing cells35,36. However,
notwithstanding its potential importance for oncogenic activities
of LIP the transcriptome data do not explain the metabolic
phenotypes induced by LIP.
In agreement with the results of the transcriptome, the
overexpression of LAP had limited effects on the proteome of
the cell. A statistical analysis did not identify significantly
regulated proteins between C/EBPβ-deficient and LAP over-
expressing cells (Supplementary Fig. 2b). On the contrary,
overexpression of LIP resulted in marked changes in the cellular
proteome with an increase in the expression of 551 proteins and a
decrease in 518 proteins (Fig. 3c). Similar to the transcriptome
analysis, functional clustering analysis (DAVID) of the down-
regulated proteins upon LIP expression showed an enrichment
for proteins with function in cell-cell interactions. Furthermore,
proteins belonging to catabolic organelles (peroxisome, lysosome
and the mitochondrial membrane) and catabolic pathways (acyl-
CoA dehydrogenase activity (fatty acid catabolism and acetyl-
CoA catabolic process) were found downregulated upon LIP
overexpression (Fig. 3d). In order to address the observed LIP-
dependent increase in glycolysis we compared the mRNA and
protein levels of glycolytic enzymes and enzymes of the pentose
phosphate pathway by filtering our omics data with the Gene
Ontology Biology Process (GOBP) annotations. Although LIP
does not significantly alter relevant mRNA levels in both
pathways, the protein levels of several enzymes of the glycolytic
(Fig. 3e and supplementary Table 1) and pentose phosphate
(Fig. 3f and supplementary Table 1) pathways are elevated in LIP
expressing cells. In addition, proteins upregulated by LIP cluster
in rRNA and mRNA metabolic processes, translation initiation
and ribosomes as well as in proteins involved in purine
biosynthesis and mitosis (DAVID) (Fig. 3g). Overall the observed
LIP-induced changes in the proteome are associated with cell
growth and proliferation. The discrepancy between the alterations
for metabolic mRNAs and proteins as well as the general
imbalance between the number of mRNAs and proteins (27
mRNAs vs. 551 proteins) that are upregulated by LIP indicate
that LIP induces post-transcriptional mechanisms to control
cellular metabolism and proliferation.
LIN28B is required for LIP-induced metabolic reprogram-
ming. In the search for regulators of cell metabolism that use
post-transcriptional mechanisms and are regulated by C/EBPβ,
we re-analysed the transcriptome data. We found the Lin28b-
transcript to be upregulated by LIP overexpression in C/EBPβ-
deficient MEFs (Fig. 4a). This was confirmed by quantitative real-
time PCR (qRT-PCR) (Fig. 4b) and immunoblot analysis
(Fig. 4c), showing that both Lin28b/LIN28B mRNA and protein
levels are strongly induced by LIP but not by LAP. Moreover, we
found strongly reduced Lin28b-mRNA and LIN28B protein
expression in the C/EBPβΔuORF MEFs that are deficient in LIP
(Fig. 4d, e). In addition, ectopic LIP expression in wt MEFs,
Hepa1-6 or T47D cells resulted in elevated Lin28b-mRNA
expression (Supplementary Fig. 3a–c). Thus, our data show that
LIP but not LAP induces LIN28B expression, a protein known to
regulate the translation of several glycolytic and mitochondrial
enzymes in order to increase cellular metabolism and energy
production5,6. We did not detect sequence reads for the Lin28b-
paralogue Lin28a in the transcriptome. In addition, the LIN28A
protein was not detected in the MEFs by immunoblot analysis
(Supplementary Fig. 4a). Note, however, that in T47D cells
LIN28A is expressed and that LIP overexpression causes an
increase in LIN28A.
To investigate the requirement of LIN28B for LIP-mediated
metabolic alterations we generated a Lin28b-knockout by
CRISPR/Cas9 genomic editing using the C/EBPβ-deficient MEFs
to create C/ebpβ/Lin28b double-knockout MEFs (Supplementary
Fig. 3e). All effects of ectopic expression of LIP or LAP on OCR
and ECAR in MEFs were abrogated by Lin28b-deficiency (Fig. 4f,
g and Supplementary Fig. 3f, g, h). Hence, these data show that
LIP induces Lin28b expression and that LIN28B is required for
LIP-mediated regulation of cell metabolism.
Next, we compared known LIN28B-bound RNAs from
published CLIP-Seq (cross-linking immunoprecipitation coupled
with high-throughput sequencing) data4 with the LIP-regulated
proteome for overlapping targets. This revealed that 255 of the
1069 differentially expressed proteins in LIP expressing cells are
translated from mRNAs that are bound by LIN28B (Fig. 4h).
Gene ontology biology process (GOBP) analysis showed that 150
of these 255 proteins are involved in metabolic processes
(GO:0008152) (Fig. 4i). In contrast, only 22 mRNAs that are
differentially expressed in LIP expressing cells, are LIN28B targets
corroborating the post-transcriptional nature of the LIP-LIN28B
regulatory effects (Supplementary Fig. 3d).
Taken together, our data show that LIN28B-regulated proteins
are upregulated by LIP and that the LIN28B function is involved
in LIP-controlled regulation of metabolism.
Regulation of Lin28b by LIP involves let-7 microRNAs. The fact
that Lin28b-mRNA is upregulated by the transcriptional repressor
LIP suggests the involvement of an intermediate repressor and
primed us to investigate the microRNA family let-7, which is
known to downregulate Lin28b-mRNA. Overexpression of LIP in
C/EBPβ-deficient MEFs led to a down regulation of most of the
eight let-7 family members (Fig. 5a), while overexpression of LAP
resulted in increased levels of let-7a, d and g (Fig. 5a). Moreover,
in the LIP-deficient C/EBPβΔuORF fibroblasts the levels of let-7a, d
and g were found increased (let-7c is decreased) (Fig. 5b). Since
LIN28B inhibits let-7 maturation we examined a potential
involvement of Lin28B in the LIP induced repression of the let-7
microRNAs. Knockout of lin28b resulted in the expected upre-
gulation of let-7 microRNAs (a, b, c, d, e, f and i) from the
different clusters (Fig. 5c). Ectopic expression of LIP in these
lin28b-ko cells suppressed the elevated let-7 microRNAs in all
tested cases (Fig. 5c). This suggests that LIP can suppress let-7
expression independently of LIN28B. Furthermore, ectopic
overexpression of LIP in human breast cancer cell lines T47D and
MCF7 led to a decrease in different let-7 microRNAs, albeit with
differences between the cell types (Supplementary Fig. 4b, c).
Taken together, these data indicate that let-7 microRNAs are
differentially regulated by C/EBPβ; the transcriptional inhibitor
LIP decreases let-7 and the transcriptional activator LAP increases
let-7.
The ENCODE database (http://genome.ucsc.edu/ENCODE/)
lists C/EBPβ-associated DNA fragments with proximity to every
let-7 gene cluster. These fragments are mostly associated with
H3K acetylation (H3K27Ac), which marks transcriptional active
regions within the genome (Supplementary Table 2). Moreover,
LIP reduces transcription while LAP increases the transcription
from a 2,6 kb C/EBPβ/H3K27Ac associated promoter-region of
the let-7a-1/f-1/d cluster using a luciferase reporter assay
previously described by others37 (Fig. 5d, e). These data indicate
that the C/EBPβ isoforms transcriptionally regulate let-7 micro-
RNA clusters.
To investigate whether transcriptional repression of let-7 by
LIP precedes activation of the let-7 target Lin28b we generated
MEFs with cumate-inducible LIP expression. Following LIP
induction, the levels of let-7d, g and i start to decrease 16 h after
LIP-induction (Fig. 5f and Supplementary Fig. 4d), while Lin28b-
mRNA levels were found increased only 48 h after LIP induction
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(Fig. 5g), supporting a mechanism where transcriptional repres-
sion of let-7 by LIP precedes the activation of Lin28b.
Next, we asked how the LIP-let-7 regulation correlates with
LIP-induced changes in the proteome. Sixty eight of the 551
proteins found upregulated in LIP overexpressing cells have
predicted let-7 binding sites in their mRNA as was retrieved from
the mirna.org database (Good mirSVR score38) (Fig. 5h). An
analysis of their gene ontology did not show any specific
metabolic pathway or metabolic cellular process (Supplementary
Fig. 4e), suggesting that Lin28b is the main let-7 target and
mediator of metabolic regulation.
LIP regulates the let-7/Lin28b circuitry in vivo. To evaluate
regulation of let-7 and Lin28b by C/EBPβ-LIP in vivo we gener-
ated a conditional LIP overexpression mouse model. A LIP
expression cassette preceded by a floxed transcriptional stop cas-
sette was integrated in the Rosa26 locus (Supplementary Fig. 5a).
Intercrossing with the general Cre-deleter mouse line pCX-Cre39
(Supplementary Fig. 5b) resulted in mice with LIP overexpression
in the investigated tissues bone marrow, skin and spleen of the
further referred to as R26LIP mice (Supplementary Fig. 5c).
To investigate in vivo effects of LIP upregulation we isolated
bone marrow of R26LIP mice since these are suitable for Seahorse
XF96 metabolic flux analysis. In the R26LIP bone marrow cells
let-7 miRs (a, c, d, e, f, g, i) were repressed and the Lin28b-mRNA
was upregulated in comparison with bone marrow cells derived
from wt control mice (Fig. 6a, b). Extracellular metabolic flux
analysis (Seahorse XF96) revealed that R26LIP BM cells have
increased OCR, ECAR (Fig. 6c) and ATP/ADP ratios (Fig. 6d).
These in vivo results are reminiscent to the LIP-mediated
metabolic alterations found in the studied cell lines (Fig. 1 and
40 kDa
255 8141230
Regulation of cellular metabolic process
0 50 100 150 200 250
Cellular process
Metabolic process
Biological regulation
Regulation of biological process
Cellular metabolic process
Primary metabolic process
Regulation of cellular process
Macromolecule metabolic process
Cellular component organization or biogenesis
Cellular component organization
Regulation of metabolic process
Cellular macromolecule metabolic process
Response to stimulus
Developmental process
a b c
h i
f g
d e
mRNAs bound by LIN28B
(CLIPseq)
Proteins
regulated by LIP
(proteome)
GOBP annotations in LIN28B targets
R
el
at
iv
e 
ex
pr
es
si
on
EV LIP LAP
Lin28b
Cebpb-ko MEF MEF
β-actin
LIN28B
β-actin
wt ΔuORF
LIP
LAP
EV
MEFCebpb-ko MEF Cebpb-ko MEF
Cebpb-ko MEF
EV LIP LAP
0
500
1000
1500
RNAseq Lin28b-mRNA
R
ea
ds
 p
er
 m
ill
io
n
edgeR:
DESeq:n.s.
***
EV LIP LAP
0
1
2
3
4
qRT-PCR Lin28b-mRNA
*
R
el
at
iv
e 
ex
pr
es
si
on
wt ΔuORF
0.001
0.01
0.1
1
10
qRT-PCR
Lin28b-mRNA
***
Cebpb-ko Cebpb +
Lin28b-ko
0
25
50
75
100
125
Maximal ECAR
m
pH
/m
in
**
***
Cebpb-ko Cebpb +
Lin28b-ko
0
50
100
150
Basal OCR
pm
ol
/m
in
**
*
***
Cebpb-ko Cebpb +
Lin28b-ko
0
20
40
60
80
100
Basal ECAR
m
pH
/m
in
*
***
Fig. 4 LIP requires Lin28b to regulate cellular metabolism. a Lin28b RNA sequencing reads in LIP or LAP expressing Cebpb-ko MEFs compared to control
empty vector (EV) (n= 3). b Relative Lin28b-mRNA expression levels by qRT-PCR (n= 3) and c immunoblot analysis of LIN28B protein expression in LIP
or LAP expressing Cebpb-ko MEFs compared to control empty vector (EV). β-actin is used for loading control. Uncropped images are shown in
Supplementary Fig. 7. d Relative Lin28b-mRNA expression levels by qRT-PCR (n= 3). e Immunoblot analysis of LIN28B protein expression in wt MEFs
compared to LIP-deficient C/EBPβΔuORF MEFs. β-actin is used for loading control. Uncropped images are shown in Supplementary Fig. 7. f Basal and
maximal ECAR of, Cebpb-ko MEFs with control empty vector (EV) or ectopic expression of LIP or LAP or with additional Lin28b-knockout (Lin28b-ko) (n=
6). g Basal OCR of Cebpb-ko MEFs with control empty vector (EV) or with ectopic expression of LIP or LAP, or with additional Lin28b-ko (n= 6). h Venn
diagram showing overlap between LIP-regulated proteins (proteome, this study) and LIN28B targets (CLIPseq4). i GOBP annotations of LIN28B targets that
are differential expressed in the LIP proteome. Statistical differences were analysed by Student’s t-tests. Error bars represent ±SD, *P < 0.05, **P < 0.01,
***P < 0.001
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-019-0461-z ARTICLE
COMMUNICATIONS BIOLOGY |           (2019) 2:208 | https://doi.org/10.1038/s42003-019-0461-z | www.nature.com/commsbio 7
f g 
Expressed let-7 targets
in proteome analysis
Upregulated proteins
by LIP overexpression
68 483533
d
a
Cebpb-ko MEF MEF
wt
ΔuORF
b
Cebpb-ko MEF
MEF
let-7 miRNAs after LIP induction
Control
16 h
24 h
48 h
Lin28b-mRNA levels
after LIP induction
H3K27Ac
Chr9
96,930,26196,927,673
Human let-7a-1/f-1/d  promoter
h
e
R
el
at
iv
e 
lu
ci
fe
ra
se
 a
ct
iv
ity
MEF
C/EBPβ-associated DNA
LIP
LAP
EV
let-7a let-7b let-7c let-7d let-7e let-7f let-7g let-7i
0.0
0.5
1.0
1.5
2.0
R
el
at
iv
e 
ex
pr
es
si
on
R
el
at
iv
e 
ex
pr
es
si
on
R
el
at
iv
e 
ex
pr
es
si
on
R
el
at
iv
e 
ex
pr
es
si
on
R
el
at
iv
e 
ex
pr
es
si
on
**
**
**
***
***
***
**
*
0
1
2
3
4
let-7a
0.0
0.5
1.0
1.5
2.0
2.5
let-7b
0
1
2
3
4
let-7e
0
1
2
3
4
let-7d
0
1
2
3
4
let-7f
0.0
0.5
1.0
1.5
2.0
let-7i
0
2
4
6
8
10
let-7c
Lin28b
ko
Lin28b
ko
Lin28b
ko
Lin28b
ko
Lin28b
ko
Lin28b
ko
Lin28b
ko
c 
let-7a let-7b let-7c let-7d let-7g let-7i
0.0
0.5
1.0
1.5
2.0
2.5
*****
*
**
EV LIP LAP
0.0
0.5
1.0
1.5
2.0
*
***
let-7d let-7g let-7i
0.0
0.5
1.0
1.5
* * * ** ** ** *
Control 16 h 24 h 48 h
0
1
2
3
**
**
**
**
Cebpb-ko MEF
p = 0.05
** ***
*** ***
*** ***
***
***
*
*
EV LIP
Fig. 5 LIP and LAP transcriptionally regulate let-7 microRNAs. a Expression levels of let-7a, b, c, d, e, f, g and i in Cebpb-ko MEFs with control empty vector
(EV) or with ectopic expression of LIP or LAP (n= 3). b Expression levels of let-7a, b, c, d, g and i in wt or C/EBPβΔuORF MEFs (n= 3). c Expression levels of
let-7a, b, c, d, e, f and i in Cebpb-ko MEFs or Cebpb/Lin28b-dko MEFs with control empty vector (EV) or with ectopic expression of LIP. d A schematic
visualization of the let-7a-1/f-1/d promoter with H3K27 acetylation and C/EBPβ-associated DNA fragments (http://genome.ucsc.edu/ENCODE/). e Bar
graph of let-7a-1/f-1/d promoter-reporter activity in response to LIP or LAP expression in MEFs compared to EV control (n= 5). f Bar graph of expression
levels of let-7d, g and i in wt MEFs and 16, 24 and 48 h after LIP induction (n= 3), and g Bar graph of the corresponding Lin28b-mRNA expression levels (n
= 3). h Venn diagram showing overlap between proteins upregulated by LIP and let-7 targets in the proteome analysis. Statistical differences were analysed
by Student’s t-tests. Error bars represent +SD, *P < 0.05, **P < 0.01, ***P < 0.001
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-019-0461-z
8 COMMUNICATIONS BIOLOGY |           (2019) 2:208 | https://doi.org/10.1038/s42003-019-0461-z | www.nature.com/commsbio
Supplementary Fig. 1). To examine whether the increased LIP
expression would result in differences in bone marrow composi-
tion we performed flow cytometry analysis after staining bone
marrow cells with antibodies specific for lineage and
differentiation-stage specific surface markers. The percentage of
lineage negative cells (LIN−) representing undifferentiated
haematopoietic stem- and multipotent progenitor cells was
increased in the bone marrow from LIP overexpressing mice
compared to control mice, suggesting that the composition of the
haematopoietic compartment in the bone marrow of LIP
overexpressing mice is more immature (Fig. 6e and Supplemen-
tary Fig. 6a, b). In addition, we observed an increase in the
percentage of lineage-negative, Sca1-negative, c-kit-positive
myeloid progenitors (LIN−Sca−Kit+) in LIP overexpressing
mice. Further analysis of the LIN−Sca+Kit+ fraction of bone
marrow cells revealed that the percentage of long-term hemato-
poietic stem cells (LT-HSCs, CD48− CD150+) which have life-
long self-renewal potential and are believed to be the most
immature cells in the bone marrow, were increased in the bone
marrow from LIP overexpressing mice (Fig. 6e and Supplemen-
tary Fig. 6a, b). In contrast, the fraction of short-term HSCs (ST-
HSCs, CD48− CD150−) that only have limited self-renewal
potential was reduced. The percentage of multipotent progenitors
(MPPs, CD48+ CD150−) that lack self-renewal capacity is not
significantly changed in the LIP overexpressing mice. Although
these analyses do not completely resolve the alterations in the
bone marrow that are induced by LIP overexpression, they point
towards a higher percentage of immature cells in the LIP
overexpressing mice.
C/EBPβ, its paralogue C/EBPα and LIN28 have been shown to
be key regulators in skin differentiation and hair follicle function
in separate studies. C/EBPβ and C/EBPα are expressed in the
nuclei of basal keratinocytes and their expression is upregulated
during differentiation with the highest expression in the stratum
granulosum. Double knockout of the functionally redundant
Cebpa and Cebpb genes in skin revealed that they are essential for,
the coupling between cell cycle exit and commitment of
epidermal differentiation through inhibition of E2F, the restric-
tion of stem cell function through downregulation of stem cell
signature genes, and the expression of key molecules in epithelial
barrier function40–42. Transgenic expression of Lin28a in mice
results in the development of a thicker skin and thicker hair coats
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due to an expanded anagen phase (active growth phase) in the
hair follicles6,43. We observed a similar epidermal thickening (in
five of six examined animals) and a shift towards anagenic hair
follicles (in four of six examined animals) in R26LIP mice that
overexpress LIP (Fig. 7a–h and Supplementary Table 3). Staining
for Keratin 1 and 5 showed that the stratification of the thickened
epithelial tissue in the R26LIP mice is preserved; Keratin 1 is
expressed in the spinous and granular layers and the strongest
staining for keratin 5 is found in the basal layer (Fig. 7i–l).
Staining for proliferating cell nuclear antigen (PCNA) showed an
increase in proliferating cells and a higher cell density in the basal
layer (average PCNA-positive cells per high-power field (HPF);
41.63 for R26LIP mice and 27.76 for wt, P= 0.0187) (Fig. 7m, n).
Taken together, these data suggest that higher proliferation of
keratinocytes in the basal layer causes the thickening of the
spinous layer in R26LIP mice.
In accordance with our in vitro results and results from the
bone marrow of R26LIP mice expression of the let-7 miRs (a, b, c,
d, e) was reduced in isolated skin of R26LIP mice (Fig. 7o) and
immunohistochemical staining showed an increase in LIN28B
protein levels in the epidermis of R26LIP mice compared to
control mice (Fig. 7p, q). Thus, our data show that upregulation
of LIP results in suppression of let-7 and consequently activation
of Lin28b in the skin, which results in epidermal thickening and
an increase in anagen hair follicles. Taken together we show that
LIP regulates the let7/LIN28B circuitry in vivo, which is
associated with metabolic reprogramming toward enhanced
glycolysis and mitochondrial respiration and results in tissue
hyperplasia.
Discussion
Here we show that the transcriptional activator C/EBPβ-LAP and
the transcriptional inhibitor C/EBPβ-LIP differentially regulate
cellular metabolism. LIP robustly enhances both the extracellular
acidification rate (ECAR) as a measurement of aerobic glycolytic
flux and the oxygen consumption rate (OCR) as a measurement
for mitochondrial respiration, while LAP only enhances respira-
tion (OCR) but to a lesser extent than observed with LIP.
Expression of LIP also increases the mitochondrial mass, which
likely contributes to the increase in respiration capacity in cells
with high LIP expression. The metabolic alterations induced by
LIP support cell growth and proliferation and are characteristic
for cancer cells2. Mechanistically, we showed that LIP requires the
RNA-binding protein LIN28B for its metabolic reprogramming
function and that LIP upregulates LIN28B through transcrip-
tional downregulation of let-7 microRNAs that are known to
target the lin28b-mRNA. By using the LIP-overexpressing
transgenic R26LIP mouse model we could recapitulate the LIP-
let7-LIN28B regulation in vivo which resulted in similar meta-
bolic changes in R26LIP bone marrow cells as was found in cell
culture experiments. Furthermore, the occurrence of hyperplasia
in the skin of the R26LIP mice suggests that aberrant induction of
the LIP-let-7-LIN28B pathway provokes the deregulation of
tissue homeostasis and therefore could support a pro-
tumourigenic state.
Earlier experiments using different mouse models have
revealed a key role of C/EBPβ in the regulation of organismal
metabolism; for example C/EBPβ deficient mice are protected
against high fat diet induced obesity44. We previously showed
that mice deficient in LIP expression but normal in LAP
expression consume more oxygen and display a metabolic shift
away from carbohydrate use toward more fatty acid oxidation,
which is accompanied by metabolic improvements reminiscent
with those found under calorie restriction24. Here, we show that
at the cellular level LAP enhances respiration but not glycolysis.
LIP on the contrary robustly increases both rate and capacity of
aerobic glycolysis and mitochondrial respiration—a condition
that resembles cancer cell metabolism. Omics analysis revealed
that LIP does not significantly alter relevant mRNA levels in
glycolytic pathways, but instead the levels of enzymes of the
glycolytic and pentose phosphate pathways are elevated. Our
study points to an important role of the LIP-let-7-LIN28B con-
trolled metabolic regulation in the context of proposed oncogenic
functions of LIP in vitro and in vivo22,25,27. The regulation of
LIN28B by LIP-let-7 predicts that the paralogue LIN28A is
similarly regulated because both Lin28a- and Lin28b-mRNAs are
known let-7 targets. While in the main experimental system used
in this study (MEFs) LIN28A is not expressed and could not be
studied, we do observe strong upregulation of LIN28A by LIP in
T47D cells (Supplementary Fig. 4a), suggesting that indeed
LIN28A can be part of the LIP-let-7-LIN28A/B regulatory circuit.
Eight conserved clusters in the mouse or human genomes
encode for the family of nine functionally redundant let-7
microRNAs (a, b, c, d, e, f, g, i and miR-98)18,45. This redundancy
is one of the reasons for the strong tumour suppressive functions
of let-7. The transcriptional regulation of let-7 in vertebrates is not
well understood. It is assumed that factors which regulate tran-
scription of several if not all clusters would be most effective in
regulating the collective function of the let-7 microRNAs18. In
this study we reveal that LIP is such a master regulator of let-7
levels and thereby activates LIN28B.
Apart from the role of the let-7 miRs relatively little is known
about the (post-)transcriptional regulation of Lin28a/b-mRNAs.
It is reported, that Lin28a/b-mRNAs are suppressed by micro-
RNA mir-125/lin-4 during stem cell differentiation46, that plur-
ipotent factors transcriptionally upregulate Lin28a in mammalian
ESCs47, and that Myc or NF-kB can transcriptionally activate
Lin28b in cancer cells45,48,49. Our experiments did not reveal
direct transcriptional regulation by LIP of the Lin28b-promoter,
nor does the ENCODE database record high-score C/EBPβ-
associated DNA fragments (http://genome.ucsc.edu/ENCODE/)
at the Lin28b-promoter. Since, repression of let-7 and/or activa-
tion of Lin28a/b will modulate the let-7/LIN28A/B circuit, reg-
ulatory factors like MYC and LIP would act either alone, or
together while reinforcing each other’s function, contribute to low
let-7/high Lin28A/B-driven metabolic reprogramming, prolifera-
tion and tumourigenesis48 (see model Fig. 8).
We have shown before that expression of LIP, involving a cis-
regulatory small uORF in the Cebpb-mRNA, is suppressed by
treatment with the mTORC1-inhibitor rapamycin24. In addition,
we have identified other FDA approved drugs in a screening
approach that suppress LIP50. Therapeutic interventions that
suppress LIP and thereby impair cancer cell metabolism could
complement existing cancer therapies. Furthermore, interfering
with glycolysis or mitochondrial respiration much stronger
affected proliferation of LIP expressing cells compared to LAP
expression or empty vector control cells (Fig. 2d). Thus, high LIP
expression could be a feature exploited for cancer diagnosis,
revealing those cancer types that are specifically sensitive to
treatment with metabolic inhibitors that are already in pre-
clinical or clinical development51. In contrast to LIP expressing
cells, LAP expressing cells seem to be resistant against rotenone
treatment (Fig. 2e). This might be explained by our earlier
observation that LAP induces fatty acid oxidation24. While the
NADH generated during fatty acid oxidation enters the respira-
tory chain at complex 1, which is inhibited by rotenone, the
generated FADH2 enters at complex II whose function is unaf-
fected by rotenone and thus could maintain sufficient energy
levels for survival and/or proliferation of these cells.
Our transcriptome analysis revealed that LIP downregulates
gene clusters with functions in the extracellular matrix, cell
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adhesion and polysaccharide binding. This suggests an oncogenic
function of LIP in cancer cell migration, which is in line with a
study showing that breast cancer cells with high LIP levels are
more aggressive and prone to migrate29,52. Metabolic repro-
gramming has been linked to metastatic potential in breast can-
cer53. Because C/EBPβ-LIP is involved in the regulation of cell
migration and cellular metabolism it could be a determining
factor for the metastatic capacity by co-regulating cell migration
and metabolism.
In the R26LIP mouse model we did not observe an increased
incidence of cancer at the investigated age of 9–12 months.
However, elevated LIP expression in a different knockin mouse
model was associated with an increased cancer incidence upon
ageing33. Therefore, LIP overexpression may not be sufficient to
initiate cancer development but collaborate with additional
oncogenic mutations and/or with age-related pathophysiological
changes to induce or support tumourigenesis. Since Lin28b
upregulation is critically involved in the development of different
tumour types it likely contributes to tumour development and/or
maintenance in tumours in which LIP levels are increased.
C/EBPβ is a known regulator of epidermal differentiation40–42
and of the anagen growth phase in hair follicles40,54. However, the
role of the different C/EBPβ protein isoforms was not addressed
in those studies. The development of skin hyperplasia in the
R26LIP mice suggests that LIP counteracts the differentiation
functions of LAP and probably also interferes with the function of
C/EBPα. The LIP overexpression in R26LIP mice is correlated
with let-7 repression and LIN28B upregulation in the skin. Since a
similar skin hyperplasia phenotype is found in LIN28A over-
expressing mice6 the let-7-LIN28 regulation is likely involved in
the epidermal functions of C/EBPβ. C/EBPβ is expressed in
hematopoietic cells of different lineages and differentiation stages.
Overexpression of LIP in the R26LIP mice with the concomitant
increase in ECAR (glycolysis) and OCR (respiration) in the bone
marrow was expected to affect haematopoiesis. Overall, the data
point towards a moderate increase of immature cells in the LIP
overexpressing mice although the reduction in short-term hae-
matopoietic stem cells (ST-HSC) could also reflect a more effi-
cient differentiation into lineage specific progenitor cells. For
more complete functional analysis of the LIP-induced alterations
in the hematopoietic system more elaborate experiments must be
performed.
C/EBPβ and let-7 are expressed in a wide range of adult tissues
(www.genecard.org) and animals with transgenic expression of
let-7 or reduced levels of LIP have reduced liver regeneration
capacities after partial hepatectomy23,55. In 3T3-L1 cells, a cellular
model for adipocyte differentiation it was shown that let-7
expression increases upon terminal differentiation into
adipocytes56. In the same model, overexpression of C/EBPβ-LIP
results in disturbed differentiation and cellular transformation22.
Our work provides a link between these observations showing
that LIP represses let-7 expression while the transcriptionally
potent LAP (and eventually other C/EBP family members) up-
regulate let-7 expression57, thereby regulating the transition
between proliferation and terminal differentiation in different
tissues. Furthermore, our findings raise the question if C/EBPβ-
let-7-LIN28B regulation plays a general role in tissue maintenance
and regeneration.
Taken together, we identified LIP as regulator of the let-7/
LIN28B circuit, which induces a metabolic shift that is a char-
acteristic of cancer cells. The possibility to target the translational
expression of LIP50 may open up opportunities to interfere with
the let-7/LIN28B circuit in tissue homeostasis and cancer.
Methods
Cell culture. HEK293T cells, Hepa1-6 cells, BT20 cells and all immortalized MEF
cell lines were cultured in high glucose DMEM supplemented with 10% FBS, 10
mM HEPES, 1 mM Sodium Pyruvate and 100 U/ml Penicillin Streptomycin. T47D
and MCF7 breast cancer cells were maintained in RPMI1640 medium supple-
mented with 10% FBS, 25 mM HEPES, 1 mM Sodium Pyruvate and 100 U/ml
Penicillin/Streptomycin. C/EBPβΔuORF MEF, Cebpb ko MEF and p53 ko MEF were
described before24.
DNA constructs. Plasmids containing rat C/EBPβ-LAP, rat C/EBPβ-LIP and flag-
tagged rat C/EBPβ-LIP were described before24. For overexpression of human C/
EBPβ-LIP, the coding sequence was amplified from MCF7 genomic DNA (forward
primer: 5’- CCGAGCTCAAGGCGGAGCC-3′, reverse primer: 5′- TAAAATTAC
CGACGGGCTCCCC-3′). The amplified PCR product was cloned into pcDNA3.1
(Invitrogen) and checked for mutation by Sanger sequencing.
Transfection. Immortalized MEFs were transfected with an empty, rat C/EBPβ-
LIP or -LAP containing pcDNA3 or pSV2Zeo vector by using Fugene HD (Pro-
mega) according to the manufactures protocol. For stable overexpression, C/EBPβ-
ko MEFs were treated with 0.2 mg/ml Zeocin (Invitrogen). To maintain the
expression cells were culture with 0.1 mg/ml Zeocin in the medium. Immortalized
wt MEFs transfected with empty pcDNA3 or LIP-containing pcDNA3 were
selected with 0.8 mg/ml G418 and to maintain the overexpression cultured with
0.5 mg/ml G418. BT20 cells, T47D cells and MCF7 cells were transfected with
empty or human LIP-containing pcDNA3.1 via Fugene HD (Promega) using the
manufactures protocol. For stable expression, MCF7 cells were selected with 0.8
mg/ml, T47D with 0.4 mg/ml and BT20 with 1.2 mg/ml G418. For lentivirus
production, 4.5 × 106 HEK293T cells were plated in 10-cm culture dishes. Twenty-
four hours later, transfection was performed using the calcium phosphate method.
Lentiviral transduction. P53−/− MEFs were infected with a cumate-inducible C/
EBPβ-LIP-FLAG construct or an empty vector construct using a standard protocol.
Two days after infections cells were selected with puromycin (1.66 µg/ml). Hepa1-6
cells were infected with an empty or C/EBPβ-LIP-FLAG containing pLVX-IRES-
neo vector and selected with 0.9 mg/ml G418.
LIN28B
Transcriptional Transcriptional
Activationlet-7
Pluripotency factors/
Proto-oncogenes
(e.g. MYC) 
C/EBPβ-LIP
Glycolysis
Mitochondrial respiration
Proliferation
Tissue repair (regeneration)
Cancer
Repression
Fig. 8 Model of a dual mode of regulating the let-7/LIN28B circuit. The transcriptional activation of LIN28B by pluripotency factors and proto-oncogenes
and the transcriptional repression of let-7 by C/EBPβ-LIP dually control the influence of the LIN28B/let-7 circuit on cellular metabolism, tissue repair
and cancer
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CRISPR/Cas gene targeting. A gRNA against mouse Lin28b was designed (5′-
CATCTCCATGATAAGTCGAGAGG-3′) and cloned into pSpCas9(BB)-2A-GFP
(PX458, Addgene plasmid #48138). Two days after electroporation (Lonza, Amaxa
MEF2 Nucleofector Kit, protocol T-20) GFP-positive cells were sorted and plated
at low density (65 cells per mm2) to form single cell colonies. After 2 weeks of
culture colonies were transferred to single wells of a 96-well plate and expanded.
Several clones were isolated and the genomic Lin28b sequence was checked by
Sanger sequencing. LIN28B protein expression was checked by immunoblot.
Proliferation assays. 5 × 104 immortalized MEFs were seated in 6-cm dishes.
After 3 days cells were trypsinised and counted using an automated cell counter
(TC20, Biorad). Cell numbers were transformed to population doublings (Formula:
Population doubling ¼ log10
final cell number
starting cell number
 
log10 2ð Þ )
For 2-Deoxyglucose (2-DG) and Rotenone treatment Cebpb-ko MEFs with
control empty vector (EV) or ectopic expression of LIP or LAP were seeded in 96-
well plates (2000 cells per well) in the presence of different concentrations of
Rotenone (0 nM; 100 nM; 250 nM; 500 nM) or 2-DG (0 mM; 1 mM; 2.5 mM; 5
mM; 10 mM) and relative viable cell numbers were determined three days later
using the CellTiter-FluorTM cell viability assay (Promega) according to the
instructions of the manufacturer.
Metabolic flux analysis. Metabolic flux analysis was performed using a Seahorse
XF96 Extracellular Flux analyser (Agilent Bioscience). 1.5 × 104 immortalized
MEFs were seeded 4 h before the assay. Cancer cell lines were seeded with different
densities (Hepa1-6, T47D: 3 × 104; BT20: 1.5 × 104) 16 h before the experiment. For
the Seahorse flux analysis of bone marrow cells, Seahorse plates were treated with
poly-L-lysine. 4 × 105 freshly isolated bone marrow cells were centrifuged into the
poly-l-lysine layers of a Seahorse plate just before the start of the assay. Assays were
performed according to the manufactures protocol. Injected drugs were oligomycin
(2.5 µM) for maximal glycolytic capacity/inhibition of ATP dependent mitochon-
drial oxygen consumption, 2,4-Dinitrophenol (50 µM) for maximal oxygen con-
sumption and 2-deoxyglucose (100 mM) for inhibition of glycolysis.
Mitochondrial analysis. Mitochondrial mass was determined by staining the cells
with the MitoTracker Red 480 kit (Thermo Fisher Scientific) according to the
instructions of the manufacturer, fixed with paraformaldehyde (3.7%), permeabi-
lized by incubation in ice-cold acetone, counterstained with DAPI as a control for
actual cell numbers and mounted on glass slides with Pro-Long Gold Antifade
Reagent (Thermo Fisher Scientific). Photographs of the fluorescent cells from
different microscopic fields were taken using a Leica DMI 6000 B fluorescence
microscope with the LAS AF software and quantified as ratio between Mitotracker
480- and DAPI staining using the ImageJ software.
Mitochondrial and genomic DNA were co-purified using a standard protocol
and the ratio between mitochondrial and genomic DNA was determined by qPCR
using the LightCycler 480 SYBR Green I Master Mix (Roche) and a cytochrome b
gene specific primer pair (for: CAT TTA TTA TCG CGG CCC; rev: TGT TGG
GTT GTT TGA TCC TG) for mitochondrial DNA and a β-actin gene specific
primer pair (for: AGA GGG AAA TCG TGC GTG AC; rev: CAA TAG TGA TGA
CCT GGC CGT) for genomic DNA.
Luciferase-based assays. NADH, NAD+, ATP and ADP levels were dis-
tinguished using luciferase-based assays. Twenty-four hours before the assay, 5000
cells per well were seeded in a 96-well plate. Experiments were performed
according to manufactures protocols (NADH/NAD+: Promega, G9071; ATP/
ADP: Biovision, K255-200).
For the luciferase-based promoter assay 2500 p53−/− MEFs were seeded 3 days
before the measurement. Two days prior the measurement cells were transfected
with empty, human LAP or human LIP containing pcDNA3.1, empty or let-7a-1/f-
1/d promoter containing pGL4.2337 and pGL4.73-renilla (for normalization) using
Fugene HD (Promega). Just before the measurement the medium was removed and
phenol red free DMEM was added. The measurement of firefly and renilla activity
was performed according to the manufactures protocol (Promega, E1910). For
detection, a GloMax-Multi Detection System (Promega) was used.
qRT-PCR analysis. Total RNA was isolated using the miRNeasy Isolation Kit
(Qiagen) following the manufactures protocol. For the analysis of microRNA
expression, cDNA was synthesized from 500 ng RNA using the miScript II RT kit
(Qiagen). qRT-PCR was performed using the miScript SYBR green PCR kit
(Qiagen) and commercially available primers for let-7a, b, c, d, e, f, g and i (Qia-
gen). Primers for Snord72 and U6 were used for normalization. For the analysis of
mRNA expression, 500 ng RNA were reverse transcribed with random hexamer
primers using the transcriptor first strand cDNA synthesis kit (Roche). qRT-PCR
was preformed using the LightCycler 480 SYBR Green I Master Mix (Roche) and
commercially available mouse and human Lin28b primers (Qiagen).
Analysis of differentially expressed genes. In general, sequencing was done
using the next-generation sequencing technology of Illumina58. RNA was isolated
from stable overexpressing C/EBPβ-LIP, C/EBPβ-LAP and empty vector control C/
EBPβ ko fibroblasts using the RNeasy Plus Mini Kit (QIAGEN). Quality and
quantity of RNA was determined using Agilent’s Bioanalyzer 2100 in combination
with the RNA 6000 nano chip (Agilent). Library preparation was done using
Illumina’s TruSeq RNA v2 following the manufacturer’s description. The libraries
were quality checked and quantified using Bioanalyzer 2100 (as mentioned above)
in combination with the DNA 7500 kit (Agilent). Sequencing was done on a
HiSeq2500 in 50 bp, single-end sequencing, high-output mode. Sequence infor-
mation was extracted using bcl2fastq v1.8.3 (Illumina), Sequencing resulted in
around 50 mio reads per sample. Obtained reads were aligned to the GRCh38/
mm10 genome (refSeq annotation from 2012-05-17) using TopHat v1.4.159 and
quantified using the HTSeq count v0.5.460. Identification of differentially expressed
genes (DEGs) was done by using the bioconductor packages (https://www.
bioconductor.org/) edgeR61 and DESeq62 in the statistical environment R. The
resulting p-values were adjusted using Benjaminin and Hochberg’s approach for
controlling the false discovery rate63. Genes were regarded as differentially
expressed if adjusted p-values of edgeR and DEseq < 0.05. The data were analysed
using R/bioconductor or Perseus software (http://www.coxdocs.org/). Functional
clustering analysis was performed using the DAVID database (https://david.ncifcrf.
gov/, version 6.7) at default settings with high stringency.
Proteome analysis. Cebpb-ko fibroblasts stably overexpressing C/EBPβ-LIP, C/
EBPβ-LAP or empty vector control were lysed using a Urea-Lysis-Buffer (8M Urea,
100 mM Tris pH 8.4). 100 μg of proteins were reduced in DTT 2mM for 30 min at
25 °C and successively free cysteines were alkylated in 11 mM iodoacetamide for 20
min at room temperature in the darkness. LysC digestion was performed by adding
LysC (Wako) in a ratio 1:40 (w/w) to the sample and incubating it for 18 h under
gentle shaking at 30 °C. After LysC digestion, the samples were diluted three times
with 50 mM ammonium bicarbonate solution, 7 µl of immobilized trypsin (Applied
Biosystems) were added and samples were incubated 4 h under rotation at 30 °C.
Digestion was stopped by acidification with 5 μl of trifluoroacetic acid and trypsin
beads were removed by centrifugation. Fifteen micrograms of digest were desalted
on STAGE Tips, dried and reconstituted to 20 µl of 0.5% acetic acid in water64,65.
We used a LC-MS/MS system (NanoLC 400 [Eksigent] coupled to Q Exactive HF
[Thermo]) and a 240 min gradient ranging from 5 to 40% of solvent B (80%
acetonitrile, 0.1% formic acid; solvent A= 5% acetonitrile, 0.1% formic acid) to
analyse 5 μl of each sample in duplicate. A MonoCap C18 HighResolution 2000
(GL Sciences) of 100 cm length was used for the chromatographic separation. The
nanospray source was operated with an ion transfer tube temperature of 260 °C
and a spay voltage of 2.4 kV. The data dependent mode was used to acquire the
data with a top 10 method (one survey MS scan with resolution 70,000 at m/z 200,
followed by up to 10MS/MS scans on the most intense ions with intensity
threshold 5000). In order to increase new sequencing events ions, once selected for
fragmentation ions were excluded from further selection for 45 s. Raw data were
analysed using the MaxQuant proteomics pipeline (v1.5.3.30) and the built in the
Andromeda search engine66 with the mouse Uniprot database. Carbamido-
methylation of cysteines was chosen as fixed modification, oxidation of methionine
and acetylation of N-terminus were chosen as variable modifications. The search
engine peptide assignments were filtered at 1% FDR and the feature match between
runs was enabled; other parameters were left as default. For statistical analysis and
visualization of the data, Perseus software was used at default settings. Functional
clustering analysis was performed using the DAVID database (https://david.ncifcrf.
gov/, version 6.7) at default settings with high stringency.
Immunoblot analysis. Cells and tissues were lysed using RIPA buffer. Equal
amounts of protein were separated via SDS-PAGE and transferred to a PVDF
membrane using Trans-Blot Turbo System (Bio-rad). The following antibodies
were used for detection: C/EBPβ (E299) from Abcam; LIN28B (mouse preferred)
from Cell Signaling Technology, β-tubulin (GT114) from GeneTex and β-actin
(clone C4) (#691001) from MP Biomedicals. For detection, HRP-conjugated sec-
ondary antibodies (Amersham Life Technologies) were used. The signals were
visualized by chemiluminescence (ECL, Amersham Life Technologies) using
ImageQuant LAS 4000 mini imaging machine (GE Healthcare Bioscience AB) and
the supplied software was used for the quantification of the bands.
Generation of the transgenic mouse line R26LIP. The coding sequence for C/
EBPβ-LIP was cloned into TV-Rosa26-LMP1/CD4067 via AscI restriction sites.
129/SV ES cells were transfected with TV-Rosa26-C/EBPβ-LIP and selected with
G418 for 7 days. Clones were tested for integration of the target vector by PCR
(fw1: 5′-AGG ACA ACG CCC ACA CAC CAG GTT AGC-3′, fw2: 5′-AGT TCA
TCA CGC GCT CCC ACT TGA AGC C-3′,rv: 5′-TTT GGG GCT CCG GCT CCT
CAG AGA GC-3′) and southern blot (digest of gDNA with MfeI and detection of
specific DNA fragment with radioactive probe). One positive clone was injected
into C57BL/6 blastocysts and chimeras were backcrossed with C57BL/6 to start the
R26-iCBLIP mouse line. R26-iCBLIP mice were crossed with general Cre-deleter
mouse line pCX-Cre39 to generate the R26LIP mouse line that was used for
experiments.
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-019-0461-z ARTICLE
COMMUNICATIONS BIOLOGY |           (2019) 2:208 | https://doi.org/10.1038/s42003-019-0461-z | www.nature.com/commsbio 13
Animals. Experimental male mice were housed at a standard 12-h light/dark
cycle at 22 °C in a pathogen-free animal facility for 9–12 months. Numbers of
mice used in the separate experiments are indicated in the figure legends. R26-
LIP mice were backcrossed for four generations into the C57BL/6J genetic
background. All of the animals were handled according to approved institutional
animal care and use committee (IACUC) protocols of the University of Gro-
ningen (#6996A).
Bone marrow isolation and FACS analysis. Bones of the legs, spin and sternum
were cleaned from soft tissues and carefully homogenised in red blood cell lysis
buffer (155 mM NH4Cl, 12 mM NaHCO3 and 0.1 mM EDTA) by pestle and
mortar. After addition of one volume of 0.2% bovine serum albumin (BSA) in PBS,
cell suspensions were spin down at 1400 RPM for 5 min at 4 °C. Cell pellets were
resuspended in 1 ml of 0.2% BSA in PBS and cell numbers were determined using
TC20 cell counter (Bio-Rad). Equal numbers of bone marrow cells were incubated
with an antibody mixture (Sca1-Pacfic blue, c-Kit-phycoerythrin, CD150-phy-
coerythrin/Cyanine7, CD48-Alexa 647 and lineage markers-Alexa 700: Ter119,
CD11b, CD3e, B220, and Gr1, all from Bio Legend) for 40 min at 4 °C in the dark,
washed and resuspended using 0.2% BSA in PBS. Cell populations were analysed
with a BD FACSCanto II Flow Cytometer (BD Bioscience) using the gating strategy
shown in Fig. S6.
Histology. Pieces of tissue were fixed with 3.7% paraformaldehyde for 48 h and
embedded in paraffin. Five micrometres-thick sections were stained with haema-
toxylin and eosin (H&E) and analysed by a pathologist. For immunofluorescent
and immunohistochemical staining, 5 µm-thick (in the case of PCNA staining 4
µm-thick) sections were backed over night at 55 °C, deparaffinized and rehydrated.
For antigen retrieval, skin sections were incubated overnight (15 min in case of
PCNA staining) in 10 mM citrate buffer at 60 °C. For the detection of Keratin 1 and
Keratin 5, slides were stained with specific antibodies (anti-Keratin 1: Biolegend,
#905601, 1:1000 and anti-Keratin 5: Biolegend, #905501, 1:4000) in the DAKO
Autostainer (Dako) using a standard protocol. For the detection of PCNA, endo-
genous peroxidase activity was blocked with 1% H2O2 in methanol and slides were
stained using the VECSTAIN ABC kit (Vector # PK4000, 1:25), the anti PCNA
antibody (Abcam # AB92552, 1:600) and a biotin-coupled goat anti rabbit sec-
ondary antibody (Vector # BA-1000, 1:250). Slides were then counterstained with
haematoxylin, dehydrated and covered using Eukitt. The anti-LIN28B staining was
performed using the Tyramide SuperBoost™ Kit (Thermo Fisher Scientific, #
B40941) and the anti-LIN28B antibody was used in a concentration of 1:100 (Cell
Signaling Technology, # 5422S). Skin sections were stained with DAPI and
mounted with non-hardening mounting medium. Images were taken using a
TissueFAXS microscope (TissueGnostics). Fluorescence signals were analysed via
the supplied software and ImageJ (https://imagej.nih.gov/ij/).
Statistics and reproducibility. For analysis of differentially expressed genes
(transcriptome) and proteome we refer to the specific sections above. Other sta-
tistical differences were calculated by Student’s t-test using GraphPad Prism 8. Data
are presented as the mean ± standard deviation (SD). Statistically significant dif-
ferences are indicated with *p < 0.05, **p < 0.01, ***P < 0.001.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNA-sequencing data as presented in Fig. 2 and Supplementary Fig. 2 are available at
NCBI’s gene expression omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/)68 with
identifier GSE110316. The mass spectrometry proteomics data as presented in Fig. 2 have
been deposited to the ProteomeXchange (http://www.proteomexchange.org) Consortium
via the PRIDE69,70 partner repository with the dataset identifier PXD010095. The source
data underlying main figures are presented in Supplementary Data 1–7.
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